Skip to content

Clinical trials

Phase 2 Leukemia, Myeloid, Acute trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 2 Country / region: Russia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20111
20131
20141
20171
20181
20194
20201
20212
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting5
Active, not recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
St. Petersburg State Pavlov Medical University8
Novartis Pharmaceuticals4
Cephalon1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
Golden Biotechnology Corporation1
Ivan S Moiseev1
OncoVerity, Inc.1
Universitätsklinikum Hamburg-Eppendorf1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute18
Myelodysplastic Syndromes9
Precursor Cell Lymphoblastic Leukemia-Lymphoma6
Myeloproliferative Disorders5
Leukemia, Biphenotypic, Acute4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive4
Graft vs Host Disease3
Leukemia3
Thrombocytopenia2
Immune System Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.